Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin
- 1 August 2001
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 114 (2) , 394-396
- https://doi.org/10.1111/j.1365-2141.2001.02943.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Further characterization of antibody and antigen in heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1999
- Heparin-induced Thrombocytopenia: IgG Binding to PF4-Heparin Complexes in the Fluid Phase and Cross-reactivity with Low Molecular Weight Heparin and HeparinoidThrombosis and Haemostasis, 1998
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- TREATMENT OF HEPARIN‐INDUCED THROMBOCYTOPENIA BY USE OF ARGATROBAN, A SYNTHETIC THROMBIN INHIBITORBritish Journal of Haematology, 1992
- Correction of Severe Heparin-Associated Thrombocytopenia with Intravenous ImmunoglobulinAnnals of Internal Medicine, 1989
- Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with plateletsBritish Journal of Haematology, 1989
- Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosisAmerican Journal of Hematology, 1988
- Immune Endothelial-Cell Injury in Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1987